Quick Answer
Aardvark Therapeutics, Inc. reported Total Assets of $117.18 million for the year ending 2025.
- Aardvark Therapeutics, Inc. showed an increase of +51.2% in Total Assets from 2024 to 2025.
- This data is from Aardvark Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2025: $157.03 million | Q2 2025: $147.48 million | Q3 2025: $133.23 million.
- Historical annual values: Fiscal year 2025: $117.18 million | Fiscal year 2024: $77.51 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: